The tremendous progress that has been made in understanding of the biology of breast cancer has resulted in discovery of many new drugs, giving patients hope and prolonged survival benefits. Metastatic breast cancer (MBC) is a dreaded disease and in the past the median overall survival of the patients suffering from this disease was 18 to 24 months. It is still the case for many subsets of MBC patients, but in majority of other types of this disease...